GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DMS Imaging SA (XBRU:ALIMG) » Definitions » ROA %

DMS Imaging (XBRU:ALIMG) ROA % : -6.65% (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is DMS Imaging ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. DMS Imaging's annualized Net Income for the quarter that ended in Dec. 2023 was €-2.87 Mil. DMS Imaging's average Total Assets over the quarter that ended in Dec. 2023 was €43.15 Mil. Therefore, DMS Imaging's annualized ROA % for the quarter that ended in Dec. 2023 was -6.65%.

The historical rank and industry rank for DMS Imaging's ROA % or its related term are showing as below:

XBRU:ALIMG' s ROA % Range Over the Past 10 Years
Min: -180.83   Med: -97.77   Max: -1.16
Current: -1.69

During the past 12 years, DMS Imaging's highest ROA % was -1.16%. The lowest was -180.83%. And the median was -97.77%.

XBRU:ALIMG's ROA % is ranked better than
81.81% of 1556 companies
in the Biotechnology industry
Industry Median: -35.42 vs XBRU:ALIMG: -1.69

DMS Imaging ROA % Historical Data

The historical data trend for DMS Imaging's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DMS Imaging ROA % Chart

DMS Imaging Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROA %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -170.54 -22.81 -1.16 -14.64 -1.70

DMS Imaging Semi-Annual Data
Dec13 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.36 -21.05 -7.86 3.52 -6.65

Competitive Comparison of DMS Imaging's ROA %

For the Biotechnology subindustry, DMS Imaging's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DMS Imaging's ROA % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, DMS Imaging's ROA % distribution charts can be found below:

* The bar in red indicates where DMS Imaging's ROA % falls into.



DMS Imaging ROA % Calculation

DMS Imaging's annualized ROA % for the fiscal year that ended in Dec. 2023 is calculated as:

ROA %=Net Income (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=-0.709/( (39.894+43.758)/ 2 )
=-0.709/41.826
=-1.70 %

DMS Imaging's annualized ROA % for the quarter that ended in Dec. 2023 is calculated as:

ROA %=Net Income (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=-2.868/( (42.535+43.758)/ 2 )
=-2.868/43.1465
=-6.65 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is two times the semi-annual (Dec. 2023) net income data. ROA % is displayed in the 30-year financial page.


DMS Imaging  (XBRU:ALIMG) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Dec. 2023 )
=Net Income/Total Assets
=-2.868/43.1465
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-2.868 / 39.496)*(39.496 / 43.1465)
=Net Margin %*Asset Turnover
=-7.26 %*0.9154
=-6.65 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) net income data. The Revenue data used here is two times the semi-annual (Dec. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


DMS Imaging ROA % Related Terms

Thank you for viewing the detailed overview of DMS Imaging's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


DMS Imaging (XBRU:ALIMG) Business Description

Traded in Other Exchanges
Address
7 Rue des Chasseurs Ardennais, Liege, BEL, 4031
DMS Imaging SA is a clinical-stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform. Its lead product is gp-ASIT+, a phase III trial for the treatment of grass pollen rhinitis. Its pipeline products consist of hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy.

DMS Imaging (XBRU:ALIMG) Headlines

No Headlines